Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Luedde

Showing results (341-350 of 461) with videos related to

Pageof 47
Sort By:
Journal of Clinical Medicine|December 23, 2023
Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic CholangiocarcinomaGuanwu Wang, Carlos C Otto, Lara R Heij, et al.
BJC Reports|September 26, 2024
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgeryLisa Heinrichs, Georg Fluegen, Sven H Loosen, et al.
Journal of Hepatology|August 26, 2018
Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasisFrancisco Javier Cubero, Jin Peng, Lijun Liao, et al.
Medical Sciences (Basel, Switzerland)|December 24, 2025
Determinants of Entero-Invasive and Non-Entero-Invasive Diarrheagenic Bacteria Among HIV-Positive and HIV-Negative Adults in GhanaHagen Frickmann, Fred Stephen Sarfo, Betty Roberta Norman, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Infection|August 29, 2024
Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumabAlexander Killer, Smaranda Gliga, Pascal Massion, et al.
JCI Insight|January 25, 2019
Polypropylene mesh implantation for hernia repair causes myeloid cell-driven persistent inflammationFelix Heymann, Klaus-Thilo von Trotha, Christian Preisinger, et al.
Journal of Clinical and Experimental Hepatology|January 6, 2025
Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver ParenchymaGuanwu Wang, Dong Liu, Tarick M Al-Masri, et al.
Gastroenterology|February 3, 2019
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4<sup>+</sup> T-Cell-Dependent Control of SenescenceJana C Mossanen, Marlene Kohlhepp, Alexander Wehr, et al.
Clinical Case Reports|June 4, 2021
Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literatureCaroline Klindt, Björn-Erik Jensen, Timo Brandenburger, et al.
Pageof 47

Showing results (341-350 of 461) with videos related to

Sort By:
Pageof 47
Journal of Clinical Medicine|December 23, 2023
Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic CholangiocarcinomaGuanwu Wang, Carlos C Otto, Lara R Heij, et al.
BJC Reports|September 26, 2024
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgeryLisa Heinrichs, Georg Fluegen, Sven H Loosen, et al.
Journal of Hepatology|August 26, 2018
Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasisFrancisco Javier Cubero, Jin Peng, Lijun Liao, et al.
Medical Sciences (Basel, Switzerland)|December 24, 2025
Determinants of Entero-Invasive and Non-Entero-Invasive Diarrheagenic Bacteria Among HIV-Positive and HIV-Negative Adults in GhanaHagen Frickmann, Fred Stephen Sarfo, Betty Roberta Norman, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Infection|August 29, 2024
Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumabAlexander Killer, Smaranda Gliga, Pascal Massion, et al.
JCI Insight|January 25, 2019
Polypropylene mesh implantation for hernia repair causes myeloid cell-driven persistent inflammationFelix Heymann, Klaus-Thilo von Trotha, Christian Preisinger, et al.
Journal of Clinical and Experimental Hepatology|January 6, 2025
Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver ParenchymaGuanwu Wang, Dong Liu, Tarick M Al-Masri, et al.
Gastroenterology|February 3, 2019
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4<sup>+</sup> T-Cell-Dependent Control of SenescenceJana C Mossanen, Marlene Kohlhepp, Alexander Wehr, et al.
Clinical Case Reports|June 4, 2021
Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literatureCaroline Klindt, Björn-Erik Jensen, Timo Brandenburger, et al.
Pageof 47